Healthcare -
Biotechnology - NASDAQ - US
$ 6.16
-0.324 %
$ 276 M
Market Cap
-11.41
P/E
YMAB - CASH & EQUIVALENTS
Cash & Equivalents YMAB - Y-mAbs Therapeutics, Inc.
78.6 M
LAST VALUE
-34.19%
2 YEAR CAGR
-11.86%
5 YEAR CAGR
0.00%
10 YEAR CAGR